210 related articles for article (PubMed ID: 30175133)
1. Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer.
Chen Y; Ma Z; Shen X; Li L; Zhong J; Min LS; Xu L; Li H; Zhang J; Dai L
Biomed Res Int; 2018; 2018():5276240. PubMed ID: 30175133
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantification of serum monounsaturated and polyunsaturated phosphatidylcholines as potential biomarkers for diagnosing non-small cell lung cancer.
Chen Y; Ma Z; Zhong J; Li L; Min L; Xu L; Li H; Zhang J; Wu W; Dai L
Sci Rep; 2018 May; 8(1):7137. PubMed ID: 29740076
[TBL] [Abstract][Full Text] [Related]
3. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
4. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
Cheng F; Wen Z; Feng X; Wang X; Chen Y
Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
[TBL] [Abstract][Full Text] [Related]
5. Screening and identification of potential novel lipid biomarkers for non-small cell lung cancer using ultra-high performance liquid chromatography tandem mass spectrometry.
Han YS; Shi LY; Chen JX; Chen J; Li ZB; Lu QQ; Zhang SQ; Liu J; Yi WJ; Jiang TT; Li JC; Huang J
Anat Rec (Hoboken); 2022 May; 305(5):1087-1099. PubMed ID: 34347376
[TBL] [Abstract][Full Text] [Related]
6. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer.
Yang Z; Song Z; Chen Z; Guo Z; Jin H; Ding C; Hong Y; Cai Z
J Pharm Biomed Anal; 2020 Feb; 180():113069. PubMed ID: 31884394
[TBL] [Abstract][Full Text] [Related]
8. Detection and verification of coexisting diagnostic markers in plasma and serum of patients with non-small-cell lung cancer.
Yu M; Sun R; Zhao Y; Shao F; Zhu W; Aa J
Future Oncol; 2021 Nov; 17(32):4355-4369. PubMed ID: 34674559
[TBL] [Abstract][Full Text] [Related]
9. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
[TBL] [Abstract][Full Text] [Related]
10. Lipid profiling in malignant mesothelioma reveals promising signatures for diagnosis and prognosis: A plasma-based LC-MS lipidomics study.
Chen Z; Song S; Yang C; Dai Z; Gao Y; Li N; Zhu J; Mao W; Liu J
Clin Chim Acta; 2022 Jan; 524():34-42. PubMed ID: 34843704
[TBL] [Abstract][Full Text] [Related]
11. Changes in serum amino acid levels in non-small cell lung cancer: a case-control study in Chinese population.
Liu K; Li J; Long T; Wang Y; Yin T; Long J; Shen Y; Cheng L
PeerJ; 2022; 10():e13272. PubMed ID: 35469201
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
[TBL] [Abstract][Full Text] [Related]
13. Assessment of plasma amino acids, purines, tricarboxylic acid cycle metabolites, and lipids levels in NSCLC patients based on LC-MS/MS quantification.
Cang S; Liu R; Mu K; Tang Q; Cui H; Bi K; Zhang Y; Li Q
J Pharm Biomed Anal; 2022 Nov; 221():114990. PubMed ID: 36208488
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.
Wang T; Liang Y; Thakur A; Zhang S; Yang T; Chen T; Gao L; Chen M; Ren H
Tumour Biol; 2016 Feb; 37(2):2299-304. PubMed ID: 26361956
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA biomarkers for detection of non-small cell lung cancer.
Hennessey PT; Sanford T; Choudhary A; Mydlarz WW; Brown D; Adai AT; Ochs MF; Ahrendt SA; Mambo E; Califano JA
PLoS One; 2012; 7(2):e32307. PubMed ID: 22389695
[TBL] [Abstract][Full Text] [Related]
16. Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer.
Zhu W; He J; Chen D; Zhang B; Xu L; Ma H; Liu X; Zhang Y; Le H
PLoS One; 2014; 9(2):e87780. PubMed ID: 24523873
[TBL] [Abstract][Full Text] [Related]
17. Serum untargeted metabolomics reveal metabolic alteration of non-small cell lung cancer and refine disease detection.
Li J; Liu K; Ji Z; Wang Y; Yin T; Long T; Shen Y; Cheng L
Cancer Sci; 2023 Feb; 114(2):680-689. PubMed ID: 36310111
[TBL] [Abstract][Full Text] [Related]
18. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
Niu L; Song X; Wang N; Xue L; Song X; Xie L
Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
[TBL] [Abstract][Full Text] [Related]
19. In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.
Liu PJ; Chen CD; Wang CL; Wu YC; Hsu CW; Lee CW; Huang LH; Yu JS; Chang YS; Wu CC; Yu CJ
Mol Cell Proteomics; 2015 Apr; 14(4):917-32. PubMed ID: 25638566
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
